Investing
By Will Feuer Shares of MeiraGTx Holdings rose after the gene-therapy company said it has received a $30 million investment from French pharmaceutical company...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
Investing
Published: March 3, 2025 at 5:34 p.m. ET A backlash over President Donald Trump’s plan to include three small and relatively risky tokens in an...
Investing
Published: Feb. 27, 2025 at 1:23 p.m. ET AMC Entertainment Holdings Inc.’s most liquid bond rallied this week, lifted by better-than-expected fourth-quarter revenue at the...
Investing
Last Updated: March 3, 2025 at 10:21 p.m. ETFirst Published: March 3, 2025 at 4:58 p.m. ET Kids who are obsessed with football may dream of...
Investing
Gold is back in fashion on Wall Street. In the three months through September investors snapped up 157 metric tons of the yellow metal...
Investing
Adriano Marchese Canadian precious-metals producer Americas Gold & Silver saw a rise in silver production in the third quarter and said the momentum should...
Investing
By Mauro Orru The European Union has approved Hitachi Rail’s acquisition of Thales’s ground-transportation business provided that the Japanese group dispose of its mainline...
Investing
Stock picker Ken Farsalas at Oberweis Asset Management is proving that the best way to trounce index funds is to fill your portfolio up...
Investing
Apple announced its latest line of processors known as M3 on Monday night, during a unique but brief primetime announcement. The third-generation of the...
Investing
Price increases helped McDonald’s beat third-quarter estimates, the company said. But customers may not be willing to put up with higher prices for much...
Investing
Revvity stock was tumbling Monday after the health sciences company missed third-quarter earnings estimates and slashed its fiscal 2023 earnings outlook. Revvity (ticker: RVTY)...
Investing
About the author: Yulia Svyrydenko is Ukraine’s minister of economy. Ukraine is fighting two wars. One is against Russia on the battlefield. And the...
Investing
Investors have been hating what drugmakers have to say about their financial results and their corporate strategies. When Bristol Myers Squibb (ticker: BMY) reported...
